These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 35981685)
1. Depression-like behaviors in mouse model of Sjögren's syndrome: A role of gut-microbiota-brain axis. Pu Y; He Y; Zhao X; Zhang Q; Wen J; Hashimoto K; Liu Y Pharmacol Biochem Behav; 2022 Sep; 219():173448. PubMed ID: 35981685 [TBL] [Abstract][Full Text] [Related]
2. Gut microbiota combined with fecal metabolomics reveals the effects of FuFang Runzaoling on the microbial and metabolic profiles in NOD mouse model of Sjögren's syndrome. Chen C; Zeng P; Yao X; Huang Z; Ling Y; Huang Y; Hou L; Li H; Zhu D; Ma W BMC Complement Med Ther; 2023 Jun; 23(1):195. PubMed ID: 37312184 [TBL] [Abstract][Full Text] [Related]
3. Time course of cytokine upregulation in the lacrimal gland and presence of autoantibodies in a predisposed mouse model of Sjögren's Syndrome: the influence of sex hormones and genetic background. Czerwinski S; Mostafa S; Rowan VS; Azzarolo AM Exp Eye Res; 2014 Nov; 128():15-22. PubMed ID: 25218176 [TBL] [Abstract][Full Text] [Related]
4. Total glucosides of paeony (TGP) alleviates Sjogren's syndrome through inhibiting inflammatory responses in mice. Li B; Liu G; Liu R; He S; Li X; Huang L; Wang Z; Li Y; Chen Y; Yin H; Fang W Phytomedicine; 2020 Jun; 71():153203. PubMed ID: 32402913 [TBL] [Abstract][Full Text] [Related]
5. A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome. Esch TR; Poveromo JD; Aikins MC; Levanos VA Scand J Immunol; 2002 Mar; 55(3):304-10. PubMed ID: 11940237 [TBL] [Abstract][Full Text] [Related]
6. NOD mouse model for Sjögren's syndrome: lack of longitudinal stability. Lodde BM; Mineshiba F; Kok MR; Wang J; Zheng C; Schmidt M; Cotrim AP; Kriete M; Tak PP; Baum BJ Oral Dis; 2006 Nov; 12(6):566-72. PubMed ID: 17054769 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of lysophosphatidic acid receptor ameliorates Sjögren's syndrome in NOD mice. Park E; Kim D; Lee SM; Jun HS Oncotarget; 2017 Apr; 8(16):27240-27251. PubMed ID: 28460477 [TBL] [Abstract][Full Text] [Related]
8. Short-chain fatty acid butyrate induces IL-10-producing B cells by regulating circadian-clock-related genes to ameliorate Sjögren's syndrome. Kim DS; Woo JS; Min HK; Choi JW; Moon JH; Park MJ; Kwok SK; Park SH; Cho ML J Autoimmun; 2021 May; 119():102611. PubMed ID: 33631650 [TBL] [Abstract][Full Text] [Related]
9. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger? Humphreys-Beher MG; Yamachika S; Yamamoto H; Maeda N; Nakagawa Y; Peck AB; Robinson CP Eur J Morphol; 1998 Aug; 36 Suppl():247-51. PubMed ID: 9825931 [TBL] [Abstract][Full Text] [Related]
10. Arginase 1 is involved in lacrimal hyposecretion in male NOD mice, a model of Sjögren's syndrome, regardless of dacryoadenitis status. Ohno Y; Satoh K; Shitara A; Into T; Kashimata M J Physiol; 2020 Nov; 598(21):4907-4925. PubMed ID: 32780506 [TBL] [Abstract][Full Text] [Related]
11. Systemic manifestations of primary Sjögren's syndrome in the NOD.B10Sn-H2 Kiripolsky J; Shen L; Liang Y; Li A; Suresh L; Lian Y; Li QZ; Gaile DP; Kramer JM Clin Immunol; 2017 Oct; 183():225-232. PubMed ID: 28526333 [TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation from patients with rheumatoid arthritis causes depression-like behaviors in mice through abnormal T cells activation. Pu Y; Zhang Q; Tang Z; Lu C; Wu L; Zhong Y; Chen Y; Hashimoto K; Luo Y; Liu Y Transl Psychiatry; 2022 Jun; 12(1):223. PubMed ID: 35650202 [TBL] [Abstract][Full Text] [Related]
13. Effects of Multi-glycosides of Tripterygium wilfordiion in the Treatment of Sjögren's Syndrome in the Non-obese Diabetic Mouse Model. Li CL; He J; Li ZG; Zheng LW; Hua H Chin J Dent Res; 2015; 18(2):95-101. PubMed ID: 26167547 [TBL] [Abstract][Full Text] [Related]
16. Effects of total glucosides of paeony for delaying onset of Sjogren's syndrome: an animal study. Li CL; He J; Li ZG; Zheng LW; Hua H J Craniomaxillofac Surg; 2013 Oct; 41(7):610-5. PubMed ID: 23333492 [TBL] [Abstract][Full Text] [Related]
17. A Glimpse Into the Microbiome of Sjögren's Syndrome. Deng C; Xiao Q; Fei Y Front Immunol; 2022; 13():918619. PubMed ID: 35911741 [TBL] [Abstract][Full Text] [Related]
18. What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome? Peck AB; Nguyen CQ Clin Immunol; 2017 Sep; 182():14-23. PubMed ID: 28478104 [TBL] [Abstract][Full Text] [Related]
19. P2Y2 nucleotide receptor up-regulation in submandibular gland cells from the NOD.B10 mouse model of Sjögren's syndrome. Schrader AM; Camden JM; Weisman GA Arch Oral Biol; 2005 Jun; 50(6):533-40. PubMed ID: 15848146 [TBL] [Abstract][Full Text] [Related]
20. Excessive synthesis of matrix metalloproteinases in exocrine tissues of NOD mouse models for Sjögren's syndrome. Yamachika S; Nanni JM; Nguyen KH; Garces L; Lowry JM; Robinson CP; Brayer J; Oxford GE; da Silveira A; Kerr M; Peck AB; Humphreys-Beher MG J Rheumatol; 1998 Dec; 25(12):2371-80. PubMed ID: 9858432 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]